NCT03751280 - Study of Efficacy of PEAR-004 in Schizophrenia | Biotech Hunter

Enrollment

112

Participants

Timeline

Start Date

December 10, 2018

Primary Completion Date

September 26, 2019

Study Completion Date

September 26, 2019

Conditions

Schizophrenia

Interventions

DEVICE

PEAR-004

PEAR-004 (an investigational digital therapeutic) or sham (control) was downloaded to the subject's phone and then the assigned application was unlocked using a prescription code provided by Pear Therapeutics. As this was a digital therapeutic device study, dose or mode of administration is not applicable.

DEVICE

Sham

PEAR-004 (an investigational digital therapeutic) or sham (control) was downloaded to the subject's phone and then the assigned application was unlocked using a prescription code provided by Pear Therapeutics. As this was a digital therapeutic device study, dose or mode of administration is not applicable.

Trial Locations (6)

32751

Novartis Investigative Site, Maitland

49548

Novartis Investigative Site, Grand Rapids

87102

Novartis Investigative Site, Albuquerque

90502

Novartis Investigative Site, Torrance

92845

Novartis Investigative Site, Garden Grove

94607

Novartis Investigative Site, Oakland